Left ventricular hypertrophy (LVH) and diastolic dysfunction (CHF-D) are the early
manifestations of cardiovascular target organ damage in patients with arterial hypertension …

Hypertensive heart disease (HHD) is a spectrum of abnormalities that represents the
accumulation of a lifetime of functional and structural adaptations to increased blood …

Hypertensive heart disease is a constellation of abnormalities that includes left ventricular
hypertrophy (LVH), systolic and diastolic dysfunction, and their clinical manifestations …

Abstract Purpose of Review Given that the life expectancy and the burden of hypertension
are projected to increase over the next decade, hypertensive heart disease (HHD) may be …

The spectrum of the cardiac complications of arterial hypertension includes heart failure
(HF), sudden death, and cardiac dysrhythmias, as well as the exacerbation of coincidental …

Left ventricular hypertrophy (LVH), a target-organ response to chronic pressure or volume
overload, is associated with its own independent risks of death in patients with hypertension …

A new paradigm is emerging related to the impact of chronic hypertension on the cardiac
parenchyma. Whereas left ventricular hypertrophy may be detected early and accurately in …

Left ventricular hypertrophy (LVH) is both a target organ response to chronic arterial
hypertension and a disorder that may be responsible for cardiovascular events. Although an …

The prevalence of left ventricular hypertrophy (LVH) rises with severity of Hypertension (HT),
age, and obesity. Its prevalence ranges from 20% in mildly hypertensive patients to almost …

Left ventricular hypertrophy (LVH) is a strong, independent predictor of cardiovascular
events and all-cause mortality. Patients with LVH are at increased risk for stroke, coronary …